Lichen International Limited
LICN · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $4 | $10 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $1 | $4 | $10 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -39% | 29.2% | -24.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 46.2% | 62.9% | 60.6% | 60.8% |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -23.2% | -16.1% | 11.6% | 40.5% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -65.6% | -29.5% | 4.2% | 29.3% |
| EPS Diluted | -33.08 | -0.46 | 0.052 | 0.26 |
| % Growth | -7,091.3% | -991.5% | -80.2% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |